Latest Lead News

Syrah Resources has secured an extension to address an alleged default under its Tesla offtake agreement, pushing the cure deadline to January 2026 while continuing negotiations.

TPG Telecom has launched a significant Reinvestment Plan offering eligible shareholders a chance to reinvest their $1.61 per share cash distribution into new shares at a 5% discount, aiming to bolster minority ownership and liquidity.

Energy World Corporation Ltd has outlined a strategic reset including a $442 million debt-to-equity conversion and is progressing towards commissioning its flagship Pagbilao LNG and power project in the Philippines, alongside advancing its Sengkang LNG facility in Indonesia.

Elders Limited has announced a fully franked ordinary dividend of AUD 0.18 per share for the half-year ending September 2025, accompanied by a Dividend Reinvestment Plan offering a modest discount.

Adavale Resources has uncovered significant resource growth potential at its London-Victoria gold deposit through historic data recovery and a new structural geology study, setting the stage for an imminent drilling campaign.

Activeport Group Ltd has launched a new AI model routing platform that leverages its GPU orchestration expertise to deliver secure, sovereign AI hosting with hybrid cloud compatibility.

Australian Critical Minerals has launched a cutting-edge geophysical survey at its Flint Project in Peru, aiming to refine drill targets within a prolific gold belt ahead of a planned 2026 drilling campaign.

ResMed Inc has updated the foreign exchange rate for its upcoming dividend payable to ASX CDI holders, impacting the Australian dollar amount investors will receive.

WAM Income Maximiser Limited has successfully raised $148 million through a Share Purchase Plan and Placement, expanding its funds under management beyond $300 million and declaring fully franked dividends with growth guidance through early 2026.

Stealth Group Holdings has acquired Hardware & Building Traders for $22 million, significantly expanding its footprint and upgrading its FY28 sales target to over $500 million. The deal positions Stealth as a formidable independent competitor in Australia’s hardware and industrial distribution market.

Starpharma’s 2025 AGM highlighted breakthrough partnerships and clinical progress, positioning the biotech for growth. Key deals with Genentech and Radiopharm Theranostics underpin a promising pipeline and expanding revenue streams.

Australian Bond Exchange narrowed its FY25 loss by 26% through disciplined cost cuts and is advancing its fintech strategy with AI-driven credit tools and tokenised asset ambitions.